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Abstract
Introduction:  Many  epidemiological  studies  have  suggested  that  human  papillomavirus  (HPV),
especially  type  16,  is  involved  in  the  genesis  of  squamous  cell  carcinoma  of  the  oral  cavity
and oropharynx,  especially  in  young,  non-smoking  patients;  thus,  its  detection  in  lesions  in  this
region is  important.
Objective:  To  clarify  the  capacity  of  the  brushing  sampling  method  to  detect  the  presence  of
HPV in  oral  or  oropharyngeal  lesions  through  polymerase  chain  reaction  (PCR)  testing,  and  to
compare the  results  with  those  obtained  by  biopsy.
Methods:  Prospective  study  of  adult  patients  with  oral  or  oropharyngeal  lesions  assessed  by
PCR, comparing  biopsy  specimens  with  samples  obtained  by  the  brushing  method.  The  study
was approved  by  the  Research  Ethics  Committee  of  the  institution.
Results:  A  total  of  35  sample  pairs  were  analyzed,  but  45.7%  of  the  brushing  samples  were
inadequate  (16/35)  and,  thus,  only  19  pairs  could  be  compared.  There  was  agreement  of  results
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in  94.7%  (18/19)  of  the  pairs,  with  HPV  identiﬁed  in  16  of  them.  HPV  DNA  was  detected  in  8.6%
(3/35) of  biopsy  and  5.7%  (2/35)  of  brushing  samples.
Conclusion:  There  was  no  statistically  signiﬁcant  difference  between  the  two  methods,  but  the
brushing sampling  method  showed  a  higher  number  of  inadequate  samples,  suggesting  that  it
is an  unreliable  method  for  surveillance.
© 2015  Associac¸ão  Brasileira  de  Otorrinolaringologia  e  Cirurgia  Cérvico-Facial.  Published  by
Elsevier Editora  Ltda.  All  rights  reserved.
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Estudo  comparativo  entre  biópsia  e  escovado  na  pesquisa  do  papilomavírus  humano
em  lesões  de  cavidade  oral  e  de  orofaringe
Resumo
Introduc¸ão:  Muitos  estudos  epidemiológicos  indicam  a  participac¸ão  do  papilomavírus  humano,
especialmente  o  tipo  16,  na  carcinogênese  dos  tumores  espinocelulares  das  cavidade  oral  e  oro-
faríngea, principalmente  em  jovens  e  não  fumantes,  sendo  portanto  importante  sua  detecc¸ão
nas lesões  desta  região.
Objetivo:  Elucidar  a  habilidade  do  escovado  em  detectar  o  papilomavírus  humano,  pela  reac¸ão
em cadeia  da  polimerase,  nas  lesões  orais  e  orofaríngeas,  comparando  os  resultados  com  os
obtidos por  biópsia.
Método:  Estudo  prospectivo  de  pacientes  com  lesões  orais  e  orofaríngeas,  pela  reac¸ão  em
cadeia da  polimerase,  no  qual  foram  pareados  os  resultados  de  amostras  obtidas  por  escovado
e por  biópsia.  A  pesquisa  foi  aprovada  pelo  Comitê  de  Ética  em  Pesquisa  da  instituic¸ão.
Resultado:  Foram  analisados  35  pares  de  amostras,  porém  estavam  inapropriadas  para  análise
45,7% (16/35)  das  amostras  obtidas  por  escovado,  e  portanto,  somente  19  pares  puderam  ser
comparados.  Em  94,7%  dos  pares  houve  concordância  dos  resultados,  sendo  encontrado  o  papi-
lomavírus  humano  -- 16  em  um  destes  pares.  O  ácido  desoxirribonucleico  do  papilomavírus
humano  foi  detectado  em  8,6%  (3/35)  das  biópsias  e  em  5,7%  (2/35)  dos  escovados.
Conclusão:  Não  houve  diferenc¸a  estatística  entre  os  métodos,  mas  como  houve  um  grande
número de  amostras  obtidas  por  escovado  inapropriadas,  este  parece  não  ser  conﬁável  para  o
rastreamento.
© 2015  Associac¸ão  Brasileira  de  Otorrinolaringologia  e  Cirurgia  Cérvico-Facial.  Publicado  por
Elsevier Editora  Ltda.  Todos  os  direitos  reservados.
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Squamous  cell  carcinoma  (SCC)  comprises  more  than  80%  of
the  mouth  and  oropharynx  carcinomas  and  its  incidence  in
the  head  and  neck  has  been  increasing  over  the  last  thirty
years,  especially  in  non-smokers  and  patients  younger  than
45  years  of  age.1--4 Syrjänen  et  al.  (1983)  were  the  ﬁrst
to  suggest  that  human  papillomavirus  (HPV)  could  also  be
involved  in  this  carcinogenesis  as  it  is  in  cervical  carcinoma;
since  then,  many  studies  have  been  performed  to  establish
the  prevalence  of  HPV  in  the  mouth  and  oropharynx,  both
in  patients  with  and  without  lesions.1,2,5,6
For  these  reasons,  it  appears  important  to  establish  an
affordable  and  reliable  surveillance  method  for  clinical  or
subclinical  infection  with  high-risk  HPV  in  oral  and  orop-
haryngeal  mucosa  for  head  and  neck  SCC  prevention.  HPV
detection  methods  in  SCC  of  the  mouth  and  oropharynx  show
broad  variations  in  sensitivity  and  speciﬁcity,  with  preva-
lence  ranging  between  0%  and  78%;  thus,  it  is  very  important
to  choose  a  method  that  has  high  sensitivity  and  speciﬁcity
for  HPV  detection.
r
e
aCurrently,  the  most  often  used  method  is  reverse
ybridization  with  degenerate  primers  labeled  with  biotin
ound  in  commercial  kits,  which  allows  the  genotyping  of
ost  types  of  high  and  low-risk  HPV.  There  are  many  factors
hat  can  affect  viral  detection,  such  as  lesion  location,  pres-
nce  or  absence  of  keratinization,  type  of  sample  collected,
nd  collection  procedure  (how  the  sample  was  collected,
reserved,  and  extracted),  in  addition  to  the  methods  used
n  detection.2,7--9
Biopsy  remains  the  preferred  method  for  obtaining
topharyngeal  lesion  material,  since,  in  addition  to  provid-
ng  a more  detailed  morphological  study,  the  biopsy  sample
llows  the  recovery  of  basal  layer  cells,  where  the  HPV  could
e  found  in  its  latent  form.3,10 However,  it  is  a  relatively
xpensive  method,  as  it  requires  the  presence  of  a  physi-
ian  and  surgical  material,  which  are  not  always  available
n  the  service  unit.This  study  aimed  to  compare,  through  polymerase  chain
eaction  (PCR)  and  linear  array  hybridization,  HPV  pres-
nce  in  material  collected  by  the  brushing  sampling  method
nd  biopsy  of  mouth  and  oropharynx  lesions,  testing  the
6v
f
M
T
w
c
g
w
>
a
l
i
u
o
s
C
m
t
d
a
l
d
s
t
l
b
b
m
b
i
c
d
t
t
b
s
w
i
t
f
p
s
t
K
a
o
i
1
s
A
i
l
t
i
T
t
X
t
f
d
N
V
d
m
d
R
A
w
A
A
s
l
c
e
t
t
(
l
i
c
t
ﬁ
t
(
t
(
r
f
i
p
i
s
1
m
p
s
m
S
O
m
t
H00  
iability  of  the  brushing  sampling  for  collection  of  material
rom  mouth  and  oropharynx  lesions.
ethods
his  was  a  prospective  cross-sectional  study  of  35  volunteers
ith  oral  or  oropharyngeal  lesions  with  indication  for  biopsy,
onsecutively  treated  at  the  otorhinolaryngology  clinic  of  a
eneral  hospital,  from  April  of  2012  to  December  of  2012,
ho  met  the  following  inclusion  criteria:  individuals  aged
21  years  of  age,  with  white  or  red,  vegetating,  inﬁltrating,
nd/or  ulcerated  lesions  in  the  oral  or  oropharyngeal  cavity
asting  more  than  15  days.  The  exclusion  criteria  were  clin-
cal  contraindication  to  the  surgical  procedure  and  antiviral
se.  HPV  screening  results  were  compared  in  the  material
btained  by  brushing  sampling  method  and  biopsy  of  the
ame  lesion.
The  project  was  approved  by  the  Human  Research  Ethics
ommittee,  registered  under  No.  192/09.  Before  being  sub-
itted  to  material  collection,  the  selected  patients  signed
he  informed  consent  and  answered  a  questionnaire  on  epi-
emiological  data  that  included  age,  gender,  tobacco  and
lcohol  consumption,  number  of  sexual  partners  during  their
ifetime  and  in  the  last  six  months,  type  of  partner,  and  the
uration  and  location  of  the  lesion.
Collection  of  the  biological  samples  was  performed  by  the
ame  professional  in  a  surgical  environment,  using  aseptic
echniques  and  locoregional  inﬁltrative  anesthesia  with  1%
idocaine.  Material  collection  was  ﬁrst  performed  using  the
rushing  sampling  method,  by  rubbing  a  Cytobrush  PlusTM
rush  over  the  lesion  using  three  forward--backward  move-
ents,  followed  by  the  biopsy  performed  with  a  scalpel
lade,  avoiding  areas  of  necrosis  and,  whenever  possible,
ncluding  tissue  adjacent  to  the  lesion.
The  brush  with  the  material  was  stored  in  a  cryovial
ontaining  0.9%  aqueous  saline  solution,  which  was  imme-
iately  frozen  in  liquid  nitrogen  at  −170 ◦C.  Subsequently,
he  biopsy  was  performed  and  the  material  was  divided  into
hree  fragments:  the  ﬁrst  was  placed  in  a  10%  formaldehyde
uffered  aqueous  solution  for  anatomopathological  analy-
is,  the  second  was  used  in  this  research,  and  the  third
as  stored  at  the  Biobank.  The  fragments  were  placed
n  separate  and  dry  cryotubes  and  immediately  frozen  in
he  same  container.  All  samples  were  transported  to  the
reezer  together,  remaining  frozen  at  −80 ◦C  until  they  were
rocessed  by  the  Molecular  Biology  Laboratory.
Samples  were  processed  according  to  existing  biosecurity
tandards.  The  in-house  method  was  used  for  DNA  extrac-
ion,  in  which  the  sample  was  digested  with  proteinase
,  followed  by  puriﬁcation  with  phenol/chloroform/isoamyl
lcohol  (25:24:1,  Invitrogen)  and  quantiﬁed  in  a  Nan-
drop1000  spectrophotometer  (Thermo  Scientiﬁc).
The  quality  of  the  obtained  DNA  was  veriﬁed  by  perform-
ng  PCR  of  human  -globin  with  the  PCO3/PCO4  primer  with
10-bp  amplicon  (Saiki  et  al.).  Both  positive  and  negative
amples  for  human  -globin  were  genotyped  using  a  Linear
rray  Hybridization  kit  (Roche  Diagnostics),  which  allows  the
dentiﬁcation  of  37  types  of  HPV  of  high  and  low  risk  through
inear  reverse  hybridization.
The  statistical  analysis  of  this  study  was  descriptive,  with
he  help  of  measures  of  location,  and  the  results  are  shown
s

t
aMarques  MPC  et  al.
n  Table  1. The  ‘‘z’’  test  was  used  for  quantitative  variables.
he  null  hypothesis  was  no  signiﬁcant  difference  between
he  two  proportions,  with  a  signiﬁcance  level  of  0.05.  The
LSTAT  2013.4.02  program  was  used  to  test  the  two  propor-
ions,  with  a  right-tailed  one-sided,  95%  conﬁdence  interval
or  the  difference  between  proportions.
The  literature  review  was  conducted  online,  using  the
atabases  of  the  US  National  Library  of  Medicine  of  the
ational  Institutes  of  Health  (PubMed)  and  the  Biblioteca
irtual  em  Saúde  (LILACS),  using  the  following  subject
escriptors:  polymerase  chain  reaction,  human  papillo-
avirus,  oral  mucosa,  oropharyngeal  mucosa,  oropharynx,
etection,  brushing,  and  biopsy.
esults
 total  of  35  individuals  were  evaluated,  26  men  and  nine
omen,  with  an  approximate  male  to  female  ratio  of  3:1.
ge  ranged  from  37  to  77  years,  with  a mean  of  54  years.
ll  individuals  declared  they  were  heterosexuals.  Regarding
ocial  habits,  11  (31.4%)  had  never  consumed  alcohol  regu-
arly,  18  (51.4%)  were  not  current  users,  and  six  (17.1%)  still
onsumed;  four  (11.4%)  had  never  smoked,  11  (31.4%)  were
x-smokers,  and  20  (57.1%)  were  current  smokers.
SCC  was  identiﬁed  in  21  (60%)  of  35  lesions  (21/35);  of
hese,  15  (71.4%)  were  moderately  differentiated  (15/21),
hree  (14.3%)  were  well-differentiated  (3/21),  and  three
14.3%)  were  poorly  differentiated  (3/21).  Of  the  remaining
esions  (14/35),  ﬁve  (35.7%)  received  an  anatomopatholog-
cal  diagnosis  of  papillomatosis,  three  (21.4%)  of  squamous
ell  papilloma;  three  (21.4%)  of  ulcerated  chronic  inﬂamma-
ory  processes,  two  (14.3%)  of  lymphoma,  and  one  (7.2%)  of
broepithelial  polyp.
As for  lesion  location,  ten  (28.6%)  were  located  on  the
ongue,  of  which  six  were  at  the  base  of  the  tongue;  nine
25.7%)  in  the  palatine  tonsil;  seven  (20%)  in  the  soft  palate;
hree  (8.6%)  in  the  cheek  mucosa;  two  on  the  mouth  ﬂoor
5.7%),  and  one  each  (2.9%)  in  the  following  locations:  ante-
ior  pillar,  uvula,  lower  lip,  and  oropharynx  mucosa.
All  samples  obtained  through  biopsy  were  100%  positive
or  -globin;  in  contrast,  in  samples  obtained  by  the  brush-
ng  sampling  method,  positivity  was  54.3%  (19/35).  Nineteen
airs  were  compared;  in  18,  there  was  agreement  concern-
ng  the  presence  or  absence  of  HPV  DNA.  Of  the  biopsy
amples,  three  lesions  were  positive  for  HPV  DNA:  type  HPV-
6  in  a  patient  also  submitted  to  the  brushing  sampling
ethod,  type  HPV-6  in  a  patient  with  base  of  the  tongue  lym-
homa  and  HPV-11  in  an  oropharynx  papilloma.  For  brushing
ampling  cases,  HPV  DNA  was  isolated  from  two  cases  of
oderately  differentiated  palatine  tonsil  SCC  (Table  1).
tatistical  analysis
f  the  35  samples  obtained  by  the  brushing  sampling
ethod,  only  19  were  analyzed,  which  were  positive  for
he  -globin  reaction,  and  of  these,  two  were  positive  for
PV  (2/19),  with  a  proportion  of  0.105263.  As  for  the  tis-
ue  samples  obtained  by  biopsy,  100%  were  positive  for
-globin,  with  three  being  positive  for  HPV,  with  a  propor-
ion  of  0.085714.  Only  a  pair  of  positive  samples  showed
greement  with  the  genotyping  of  the  correspondent
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Table  1  Characteristics  of  the  samples  and  results  obtained  by  PCR  of  the  -globin  gene,  viral  DNA  detection,  genotyping  by
linear array  hybridization  of  the  material  obtained  by  biopsy,  and  brushing  sampling  methods.
Case  Characteristics  of  lesions  Brushing  sample  Tissue  sample
-Globin DNA  HPV  -Globin  DNA  HPV
1  Tongue  SCC  Yes  No  Yes  No
2 Palatine  tonsil  SCC  Yes  No  Yes  No
3 Oral  mucosa  SCC  Yes  No  Yes  No
4 Palatine  tonsil  SCC  Yes  HPV-52  Yes  No
5 Ulcerated  inﬂammatory  process  of  palatine  tonsil Yes  No  Yes  No
6 Papillomatosis  of  oral  cheek  mucosa Yes No  Yes No
7 Base  of  the  tongue  SCC Yes No  Yes No
8 Ulcerated  inﬂammatory  process  of  the  mouth  ﬂoor No  No  Yes No
9 Hodgkin’s  lymphoma  of  base  of  the  tongue  No  No  Yes  HPV-6
10 Palatine  tonsil  SCC  No  No  Yes  No
11 Soft  palate  papillomatosis  No  No  Yes  No
12 Soft  palate  papillomatosis No  No  Yes  No
13 Mouth  ﬂoor  SCC No  No  Yes  No
14 Lower-lip  SCC No  No  Yes  No
15 SCC  of  the  base  of  the  tongue No  No  Yes  No
16 Ulcerated  inﬂammatory  process  of  the  oral  cheek  mucosa No  No  Yes  No
17 Tongue  SCC Yes No  Yes  No
18 Soft  palate  papillomatosis No  No  Yes  No
19 Palatine  tonsil  papillomatosis No  No  Yes  No
20 SCC  of  the  base  of  the  tongue No  No  Yes No
21 Oropharyngeal  squamous  papilloma  No  No  Yes  HPV-11
22 Non-Hodgkin  lymphoma  of  palatine  tonsil  Yes  No  Yes  No
23 Soft  palate  SCC  Yes  No  Yes  No
24 Tongue  SCC  Yes  No  Yes  No
25 Palatine  tonsil  SCC  No  No  Yes  No
26 Palatine  tonsil  SCC  Yes  No  Yes  No
27 Palatine  tonsil  SCC  Yes  HPV-16  Yes  HPV-16
28 SCC  of  the  base  of  the  tongue  Yes  No  Yes  No
29 Tongue  squamous  papilloma  No  No  Yes  No
30 Fibroepithelial  polyp  of  the  soft  palate  Yes  No  Yes  No
31 Squamous  papilloma  of  the  anterior  pillar  Yes  No  Yes  No
32 SCC  of  the  uvula  Yes  No  Yes  No
33 Soft  palate  SCC  Yes  No  Yes  No
34 Tongue  SCC  Yes  No  Yes  No
35 Soft  palate  SCC  No  No  Yes  No
HPV, human papillomavirus; DNA, deoxyribonucleic acid; SCC, squamous cell carcinoma.
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tsample  obtained  by  the  brushing  method.  The  XLSTAT
2013.4.02  program  was  used  to  test  the  two  proportions.  The
z-test  for  two  proportions  was  right-tailed  and  one-sided,
with  a  95%  conﬁdence  interval.  The  difference  between  the
proportions  was  0.020  and  the  z  (observed  value)  was  0.230,
with  z  (critical  value)  of  1.645  and  p-value  (one-sided)  of
0.409;  showing  that  there  was  no  statistically  signiﬁcant  dif-
ference  between  the  proportions  of  HPV  in  both  types  of
samples.
DiscussionHead  and  neck  tumors  have  a  global  incidence  of  460,000
new  cases  per  year,  leading  to  228,000  deaths  estimated  in
2014,  according  to  the  National  Cancer  Institute  of  Brazil.
HPV-16  is  responsible  for  25%  of  all  squamous  cell  carcinomas
t
i
t
rf  the  head  and  neck,  and  it  is  present  in  45--90%  of  all  cases
f  oropharynx  tumors  and  approximately  24%  of  larynx  and
ral  cavity  tumors.3
For  this  study,  the  number  of  cases  was  established  based
n  the  literature,  where  the  prevalence  of  HPV  in  mouth
nd  pharynx  lesions  is  approximately  36%  (p  =  0.36),  with  an
stimated  error  of  3%  to  deﬁne  the  sample  size  required  for
he  analysis.11--17
In  Brazil,  in  individuals  without  lesions  and  with  small
amples  up  to  100  individuals,  the  prevalence  of  HPV
anged  from  0%  to  12%,18--21 whereas  in  other  countries,
he  prevalence  ranged  from  0%22 to  97%,23 suggesting  that
he  prevalence  of  oral  and  oropharyngeal  infection  by  HPV
n  the  Brazilian  population  is  low;  however,  a  popula-
ion  screening  study  is  necessary  to  better  understand  the
eal  prevalence  of  HPV  in  the  oropharyngeal  cavity  of  the
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102  
razilian  population.  In  this  study,  the  high-risk  HPV  types,
PV-16  and  HPV-52,  and  the  low-risk  types,  HPV-6  and  HPV-
1,  were  identiﬁed,  with  an  overall  prevalence  of  11.4%.  The
revalence  of  HPV  in  oral  and  oropharyngeal  lesions  is  very
ide-ranging,  varying  from  0%24 to  77.8%9 and  in  national
tudies  ranging  from  0%7 to  75%19;  it  was  not  possible  to  reli-
bly  compare  the  results,  as  the  studies  had  very  different
ethodologies.
The  prevalence  of  HPV  is  higher  in  patients  who  had  other
exually  transmitted  diseases,25 with  a  large  number  of  oral
ex  partners  a  predictive  factor  for  oral  HPV  detection.23
owever,  contrary  to  what  has  been  expounded,  study  sub-
ects  who  had  more  than  twenty  sexual  partners  did  not  have
PV  DNA  detected  in  their  lesions.
To  date,  there  is  no  consensus  on  the  best  sample  collec-
ion  technique  for  patients  with  oral  and  oropharynx  lesions;
he  development  new  studies  are  required,  and  thus  it  is
mportant  to  compare  the  methods.
When  the  brushing  and  biopsy  sampling  methods  were
ompared  in  this  study  in  samples  with  mouth  or  orophar-
nx  SCC,  there  was  no  statistical  difference  between  the
ethods,  with  94.7%  (18/19)  agreement  in  pairs  of  samples.
ermine  et  al.,  in  a  similar  study,  but  not  in  oropharyngeal
esions,  observed  that  the  frequency  of  detection  through
rushing  and  biopsy  sampling  methods  also  showed  no  statis-
ically  signiﬁcant  difference,  but  the  biopsy  method  showed
o  be  more  accurate  in  high-risk  HPV  detection.26
Lawton  et  al.  assessed  three  sampling  methods  and  con-
luded  that  mouth-rinsing,  when  used  alone  is  the  best
ethod,  but  positivity  can  be  increased  when  combined
ith  other  methods  for  material  collection.27 Jarboe  et  al.
valuated  the  effectiveness  of  the  hybrid  capture  in  two
ral  brushing  and  oral  rinsing  samples,  ﬁnding  greater
etection  in  brushed  samples  than  in  those  from  mouth-
insing.28 Read  et  al.  compared  three  methods,  and  the
outh-rinsing  method  showed  higher  detection  sensitivity,
specially  in  those  individuals  who  had  brushed  their  teeth
efore  rinsing.23
Even  though  the  brushing  sampling  method  was  per-
ormed  according  to  standardized  procedures  and  following
reviously  established  protocols,  45.7%  of  the  samples
16/35)  were  inadequate  for  HPV  screening,  suggesting  low
ensitivity  of  the  collection  method,  or  incapacity  of  the
rush,  intended  for  use  in  gynecological  collection,  to  obtain
aterial  from  the  mouth  and  oropharynx  lesions,  or  because
he  medium  in  which  samples  were  placed  was  not  able  to
reserve  them.  Perhaps  the  choice  of  ﬁxation  and  preser-
ation  solutions  to  be  used  with  the  brushing  sampling
ethod,  such  as  PreservCytTM solution,2 DigeneTM solution,29
nd  phosphate-buffered  saline  (PBS)2,15,26,29--31 may  result  in
etter  samples  for  cytological  analysis  than  those  placed  in
aline  solution,  as  that  used  in  this  research.  The  comparison
etween  the  ﬁxation  solutions  of  the  mouth  and  oropharynx
aterials  collected  through  the  brushing  sampling  method
ould  clarify  this  doubt.
These  results  conﬁrm  the  involvement  of  HPV  in  oral
nd  oropharyngeal  lesions,  but  further  studies  are  needed
o  detail  the  collection  method,  with  the  investment  in
peciﬁc  kits  that  can  detect  scarce  cells,  which  will  allow
etter  identiﬁcation  of  HPV  in  these  HPV-related  oral  and
ropharyngeal  lesions,  resulting  in  improved  prevention  and
reatment.
1Marques  MPC  et  al.
onclusions
here  was  no  statistical  difference  between  the  brushing
nd  biopsy  methods  for  detection  of  viral  DNA  in  oral  and
ropharyngeal  lesions,  but  the  large  number  of  inadequate
amples  obtained  by  brushing  suggests  this  method  is  inefﬁ-
ient  when  obtaining  samples  from  this  type  of  lesion.
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